Summary for ARTG Entry:
IRBESARTAN/HCT SZ 150/12.5 irbesartan 150mg / hydrochlorothiazide 12.5mg film-coated tablet bottle
ARTG entry for
Sandoz Pty Ltd
54 Waterloo Road,Macquarie Park, NSW, 2113
ARTG Start Date
Drug Safety Evaluation Branch
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. IRBESARTAN/HCT SZ 150/12.5
Single Medicine Product
See Product Information and Consumer Medicine Information for this product
Treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.
Additional Product information
Store below 25
Protect from Moisture
Pack Size/Poison information
(S4) Prescription Only Medicine
Tablet, film coated
Route of Administration
Apricot, oval biconvex film-coated tablet, debossed with 150H on one side.
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 29.11.2017 at 03:11:07 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information